Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ · Healthcare
Crinetics Pharmaceuticals Inc. Total Liabilities 2016–2025
Crinetics Pharmaceuticals Inc. annual total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Crinetics Pharmaceuticals Inc. total liabilities as of December 31, 2025: 134.2M, a 22.21% increase year-over-year.
- Crinetics Pharmaceuticals Inc. total liabilities for 2025 were 134.2M, a 22.21% increase from 2024.
- Crinetics Pharmaceuticals Inc. total liabilities for 2024 were 109.8M, a 14.07% increase from 2023.
- Crinetics Pharmaceuticals Inc. total liabilities for 2023 were 96.2M, a 168.49% increase from 2022.
- Crinetics Pharmaceuticals Inc. total liabilities for 2022 were 35.8M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Crinetics Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $134 |
| 2024 | $110 |
| 2023 | $96 |
| 2022 | $36 |
| 2021 | $19 |
| 2020 | $15 |
| 2019 | $13 |
| 2018 | $11 |
| 2017 | $1 |
Crinetics Pharmaceuticals Inc. Total Liabilities — FAQ
Crinetics Pharmaceuticals Inc. (CRNX) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRNX's total liabilities history?
The chart and table above show Crinetics Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.